Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients Kishnani, P. S., Attarian, S., Borges, J., Bouhourd, F., Chien, Y., Choi, Y., Clemens, P., Day, J., Diaz-Manera, J., Erdem-Ozdamar, S., Goker-Alpan, O., Illarioshkin, S., Kostera-Pruszczyk, A., Kushlaf, H., Ladha, S., Mozaffar, T., Roberts, M., Straub, V., Toscano, A., van der Ploeg, A., Haack, K., Huynh-Ba, O., Zhou, T., Dimachkie, M., Schoser, B. ACADEMIC PRESS INC ELSEVIER SCIENCE. 2021: S57

View details for DOI 10.1016/j.ymgme.2020.12.127

View details for Web of Science ID 000614651500123